Recruiting Lupus Nephritis Studies in Newark
About Lupus Nephritis Clinical Trials in Newark
Lupus nephritis is kidney inflammation caused by systemic lupus erythematosus, occurring in up to 60% of SLE patients. It can lead to kidney failure if untreated. Treatment includes immunosuppressive medications such as mycophenolate, cyclophosphamide, and newer agents like voclosporin.
There are currently 2 lupus nephritis clinical trials recruiting participants in Newark, NJ. These studies are seeking a combined 350 participants. Research is being sponsored by Rutgers, The State University of New Jersey. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lupus Nephritis Clinical Trials in Newark — FAQ
Are there lupus nephritis clinical trials in Newark?
Yes, there are 2 lupus nephritis clinical trials currently recruiting in Newark, NJ. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Newark?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Newark research site will contact you about next steps.
Are clinical trials in Newark free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Newark studies also compensate for your time and travel.
What lupus nephritis treatments are being tested?
The 2 active trials in Newark are testing new therapies including novel drugs, biologics, and treatment approaches for lupus nephritis.
Data updated July 22, 2026 from ClinicalTrials.gov